Long-course targeted therapy with bevacizumab to predict better survival in patients with advanced colorectal cancer.
Yanhong Deng
No relevant relationships to disclose
Yuting Tang
No relevant relationships to disclose
Jian Xiao
No relevant relationships to disclose
Jiayu Ling
No relevant relationships to disclose
Yue Cai
No relevant relationships to disclose
Huabin Hu
No relevant relationships to disclose
Yan Zhang
No relevant relationships to disclose
Yiheng Lin
No relevant relationships to disclose
Dianke Chen
No relevant relationships to disclose